Structural racism and limited resources can pose barriers to type 2 diabetes care in Black patients. A Black physician and ...
Berberine ursodeoxycholate, a novel gut-liver metabolic modulator, reduces A1c levels and improves glycemic, cardiometabolic, ...
Novo Nordisk said on Monday its experimental next-generation drug CagriSema helped overweight or obese patients with type 2 ...
Women with diabetes are at a higher risk of heart disease due to various factors such as hormonal imbalance and atypical ...
Type 2 diabetes is a global health challenge affecting more than 400 million adults. While it is often seen as a lifelong ...
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Learn about diabetes types, symptoms, causes, and management in this comprehensive guide. Empower yourself with knowledge to ...
Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among ...
Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.
Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...
Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...
Discover simple lifestyle changes backed by research that can significantly lower your type 2 diabetes risk without requiring ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results